PF-07104091 as a Single Agent and in Combination Therapy

Clinical trial NCT04553133 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04553133
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Ovarian Cancer Breast Cancer

Start date: 2020-09-16
Primary completion: 2026-12-31
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.